间质性肺疾病进展性纤维化表型的可能机制探讨
间质性肺疾病(ILD)患者中一部分会发展为进展性纤维化表型(PF-ILD),其行为类似特发性肺纤维化。本文提供框架,探讨驱动进展的潜在机制,包括遗传易感性、衰老、表观遗传、结构纤维化扭曲、细胞外基质异常及促纤维化细胞亚群出现。理解这些机制有助于识别风险因素和制定治疗策略。
要点
- PF-ILD并非独立疾病实体,而是一组具有相似临床行为的ILD。
- 部分ILD患者在适当治疗后仍进入不可逆纤维化进展阶段。
- 进展机制涉及遗传、衰老、表观遗传及细胞外基质异常等。
核心结论
- PF-ILD是不同病因ILD患者共有的进展性纤维化表型,其机制涉及多因素交互。
研究设计与样本
- 本文为综述,探讨驱动ILD进展性纤维化表型的可能机制框架。
主要发现
- PF-ILD表型可发生于病因和生物病理学不同的ILD中。
- 部分ILD患者在进入进展性纤维化阶段前有改善或稳定的潜力。
- 进展机制包括遗传易感性、衰老、表观遗传、结构纤维化扭曲、细胞外基质异常及促纤维化细胞亚群。
临床怎么用
- 理解PF-ILD的细胞和分子机制有助于识别风险因素和制定治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Interstitial lung diseases (ILDs) comprise a large and heterogeneous group of disorders of known and unknown aetiology characterised by diffuse damage of the lung parenchyma. In recent years it has become evident that patients with different types of ILD are at risk of developing progressive pulmonary fibrosis, known as progressive fibrosing ILD (PF-ILD). This is a phenotype that behaves similar to idiopathic pulmonary fibrosis, the archetypical example of progressive fibrosis. PF-ILD is not a distinct clinical entity but describes a group of ILDs with similar clinical behaviour. This phenotype may occur in diseases displaying distinct aetiologies and different biopathology during their initiation and development. Importantly, these entities may have the potential for improvement or stabilisation prior to entering the progressive fibrosing phase. The crucial questions are: 1) why does a subset of patients develop a progressive and irreversible fibrotic phenotype even with appropriate treatment? and 2) what are the possible pathogenic mechanisms driving progression? Here, we provide a framework highlighting putative mechanisms underlying progression, including genetic susceptibility, ageing, epigenetics, structural fibrotic distortion, aberrant composition and stiffness of the extracellular matrix, and the emergence of distinct pro-fibrotic cell subsets. Understanding the cellular and molecular mechanisms behind PF-ILD will provide the basis for identifying risk factors and appropriate therapeutic strategies.
引用
- Selman M, Pardo A. When things go wrong: exploring possible mechanisms driving the progressive fibrosis phenotype in interstitial lung diseases. Eur Respir J. 2021. PMID: 33542060. doi:10.1183/13993003.04507-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。